Search results
Found 9665 matches for
Researchers at the MRC Weatherall Institute of Molecular Medicine have recently discovered why a class of cancer drugs is beneficial only in a subset of patients. The results could pave the way for the future development of these drugs, known as PNP-inhibitors, as personalised medicines.
MRC WIMM lab projects managed through other Oxford DPhil programmes
The MRC WIMM hosts research groups from various departments in the Medical Sciences Division, in addition to those from the Radcliffe Department of Medicine. Projects advertised here are offered by WIMM supervisors through DPhil programmes other than the RDM DPhil in Medical Sciences.